Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of Post‐translational Modifications in Alzheimer's Disease

21 Dec 2019

Abstract excerpt

The global burden of Alzheimer's disease (AD) is growing. Valiant efforts to develop clinical candidates for treatment have continuously met with failure. Currently available palliative treatments are temporary and there is a constant need to search for reliable disease pathways, biomarkers and drug targets for developing diagnostic and therapeutic tools to address the unmet medical needs of AD. Challenges in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cholinesterase and Neurodegenerative Diseases
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31863723
DOI: 10.1002/cbic.201900573

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of Post‐translational Modifications in Alzheimer's DiseasePMID 31863723Read ↗

Protein modification in neurodegenerative diseasesSemantic proximity Read ↗

Mapping Post-Translational Modifications in Brain Regions in Alzheimer's Disease Using Proteomics Data MiningSemantic proximity Read ↗

Proteomics of Alzheimer's disease: Unveiling protein dysregulation in complex neuronal systems.Semantic proximity Read ↗

Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in NeurodegenerationSemantic proximity Read ↗

Proteomic Insight Into Alzheimer's Disease Pathogenesis PathwaysSemantic proximity Read ↗

Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body DisordersSemantic proximity Read ↗

Early Stage Glycosylation Biomarkers in Alzheimer’s DiseaseSemantic proximity Read ↗

Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discoverySemantic proximity Read ↗

Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.Semantic proximity Read ↗

Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?Semantic proximity Read ↗

Role of primary aging hallmarks in Alzheimer´s diseaseSemantic proximity Read ↗

[Conformationally altered proteins cause neurodegenerative diseases].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.